Detection of Δ6-methyltestosterone in a "dietary supplement" and GC-MS/MS investigations on its urinary metabolism

Toxicology Letters

Volumn 201, Issue 2, 2011, Pages 101-104

  Parr, Maria K ^a   Fußhöller, Gregor ^a   Schlörer, Nils ^b   Opfermann, Georg ^a   Geyer, Hans ^a   Rodchenkov, Grigory ^c   Schänzer, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Moscow Antidoping Centre   (Russian Federation)

Author keywords

6 Methyltestosterone; Designer steroid; Doping control; GC MS; Metabolism; NMR; Supplement

Indexed keywords

METHYLTESTOSTERONE;

ARTICLE; DIET SUPPLEMENTATION; EPIMER; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLITE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; URINARY EXCRETION;

DIETARY SUPPLEMENTS; DOPING IN SPORTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; METHYLTESTOSTERONE; MIDDLE AGED; REFERENCE STANDARDS; TANDEM MASS SPECTROMETRY;

EID: 79651473505     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.11.018     Document Type: Article

References (19)

1. Brooker L., Parr M.K., Cawley A., Flenker U., Howe C., Kazlauskas R., Schänzer W., George A. Development of criteria for the detection of adrenosterone administration by gas chromatography-mass spectrometry and gas chromatography-combustion-isotope ratio mass spectrometry for doping control. Drug Testing and Analysis 2009, 1:587-595.
2. Geyer H., Schänzer W., Mareck-Engelke U., Nolteernsting E., Opfermann G. Screening procedure for anabolic steroids-control of hydrolysis with deuterated androsterone glucuronide and studies with direct hydrolysis. Recent Advances in Doping Analysis 1998, vol. 5:99-102. Sport und Buch Strauss, Köln.
3. Kazlauskas R. Miscellaneous projects in sports drug testing at the National Measurement Institute, Australia 2005. Recent Advances in Doping Analysis 2006, vol. 14:129-140. Sport und Buch Strauß, Köln.
4. Kazlauskas R. Supplements & WADA list. Recent Advances in Doping Analysis 2007, vol. 15:31-40. Sport und Buch Strauß, Köln.
5. Parr M., Geyer H., Opfermann G., Schänzer W. Prescription drugs and new anabolic steroids in nutritional supplements. Recent Advances in Doping Analysis 2004, vol. 12:71-80. Sport und Buch Strauß, Köln.
6. Parr M., Opfermann G., Schänzer W. Analytical properties of 4-hydroxysteroids and some esters. Recent Advances in Doping Analysis 2004, vol. 12:129-139. Sport und Buch Strauß, Köln.
7. Parr M.K., Opfermann G., Piper T., Schlörer N., Fußhöller G., Thomas A., Thevis M., Schänzer W. Characterisation of steroid metabolites recently detected in doping control analyses. Recent Advances in Doping Analysis 2007, vol. 15:143-152. Sport und Buch Strauß, Köln.
8. Parr M.K., Geyer H., Gütschow M., Haenelt N., Opfermann G., Piper T., Thevis M., Schänzer W. New steroids on the "Supplement" Market. Recent Advances in Doping Analysis 2008, vol. 16:73-82. Sport und Buch Strauß, Köln.
9. Parr M.K., Kazlauskas R., Schlörer N., Opfermann G., Piper T., Schulze G., Schänzer W. 6 alpha-methylandrostenedione: gas chromatographic mass spectrometric detection in doping control. Rapid Commun. Mass Spectrom. 2008, 22:321-329.
10. Parr M.K., Fußhöller G., Schlörer N., Opfermann G., Piper T., Rodchenkov G., Schänzer W. Metabolism of androsta-1,4,6-triene-3,17-dione and detection by gas chromatography/mass spectrometry in doping control. Rapid Commun. Mass Spectrom. 2009, 23:207-218.
11. Parr M.K., Gütschow M., Daniels J., Opfermann G., Thevis M., Schänzer W. Identification of steroid isoxazole isomers marketed as designer supplement. Steroids 2009, 74:322-328.
12. Schänzer W., Opfermann G., Donike M. 17-epimerization of 17-alpha-methyl anabolic-steroids in humans - metabolism and synthesis of 17-alpha-hydroxy-17-beta-methyl steroids. Steroids 1992, 57:537-550.
13. Schänzer W., Donike M. Metabolism of anabolic-steroids in man-synthesis and use of reference substances for identification of anabolic-steroid metabolites. Anal. Chim. Acta 1993, 275:23-48.
14. Schänzer, W., 2008. Personal communication.
15. Soe K.L., Soe M., Gluud C. Liver pathology associated with the use of anabolic-androgenic steroids. Liver 1992, 12:73-79.
16. Van Eenoo P., Mikulèíková P., Deventer K., VanThuyne W., Delbeke F. Metabolism, excretion and detection of androst-4-ene-3,6,17-trione. Recent Advances in Doping Analysis 2005, vol. 13:57-64. Sport und Buch Strauß, Köln.
17. Van Eenoo P., Delbeke F.T. Metabolism and excretion of anabolic steroids in doping control-new steroids and new insights. J. Steroid Biochem. Mol. Biol. 2006, 101:161-178.
18. Vida J.A. Androgens and Anabolic Agents 1969, Academic Press, New York and London, 327pp.
19. World Anti-Doping Agency, 2009. The 2010 Prohibited List. 2010 vol. World Anti-Doping Agency.